(MTF 35) 20 Months Feminizing HRT
    Transgender 2/18/2026

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Bicalutamide →

    a nonsteroidal anti-androgen, most commonly used orally for women

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 feminizing HRT (oral) daily 20 months
    💊 Dutasteride (oral) 0.5 mg daily 14 months
    💊 Bicalutamide (oral) 50 mg daily 8 months
    the tone is 😀 positive with more than I hoped, less than I wanted results.

    Other terms

    A 35-year-old transgender woman experienced hair regrowth with feminizing HRT, adding dutasteride and bicalutamide, and plans a hair transplant for further improvement. Estrogen also improved skin appearance, and the user advises against cisgender men using feminizing HRT for hair regrowth.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community (MTF 35) Results of 18 Months of HRT

       775 upvotes 8 months ago
      A transgender woman experienced significant hair regrowth after 18 months of hormone replacement therapy (HRT) with estrogen and bicalutamide. The discussion notes HRT's effectiveness for hair regrowth but warns against its use for cisgender men due to feminizing effects.

      community Transplant Candidate? (26, Male)

       40 upvotes 7 months ago
      A 26-year-old male considering a hair transplant is using topical finasteride and minoxidil, planning to start feminizing hormone replacement therapy (HRT) with estrogen and spironolactone. Many suggest waiting to see the effects of HRT, which may significantly regrow hair, before deciding on a transplant, and recommend adding microneedling and possibly switching to oral treatments for better results.

      community Can I take bicalutamide for hair loss as a man, but don’t want to transition?

      in Treatment  4 upvotes 5 months ago
      A 23-year-old man with hair loss, despite using dutasteride, oral minoxidil, and RU58841, is considering bicalutamide for regrowth but is concerned about feminization. Alternatives like topical estrogen, JXL069, and spironolactone are discussed, with suggestions to explore thyroid levels and other potential underlying conditions.

      community Medium progress pics (30yo MTF)

       179 upvotes 2 months ago
      A 30-year-old MTF individual shares their hair regrowth journey using feminizing HRT, Minoxidil, and occasional dermarolling, noting significant progress but acknowledging ongoing challenges with thin hair. They express hope for continued improvement and consider a future hair transplant if necessary.

    Related Research

    6 / 6 results
      Transgender and Migraine: Impact of Hormone Therapy

      research Transgender and Migraine

      7 citations , January 2019 in “Headache”
      This source suggests that migraine prevalence increases in transgender women using oestrogen and decreases in transgender men using testosterone, with high oral oestrogen doses in transgender women potentially linked to aura risk.
      Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)

      research Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)

      26 citations , December 2016 in “Psychiatric Clinics of North America”
      This review describes current medical and surgical treatments for transgender men, highlighting the effectiveness and general tolerability of hormone treatment, and suggesting that surgical benefits often surpass associated risks, although it reports no new clinical findings.
      Cross-Sex Hormone Therapy for Gender Dysphoria

      research Cross-sex hormone therapy for gender dysphoria

      21 citations , November 2014 in “Journal of Endocrinological Investigation”
      This review discusses cross-sex hormone therapy for managing gender dysphoria in transsexual individuals and reports no new clinical results; it highlights the need for education and culturally sensitive training for healthcare professionals.
      Management of Transgender Patients in Critical Care

      research Management of transgender patients in critical care

      5 citations , December 2022 in “˜The œjournal of the Intensive Care Society/Journal of the Intensive Care Society”
      This review discusses the challenges and considerations in managing transgender patients in critical care, noting gaps in current medical curricula and suggesting improvements in education.